AC Immune's Series D Round

AC Immune raised a round of funding on January 09, 2014. Investors include dievini Hopp BioTech Holding & Co..

AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials. The Company designs, discovers and develops …

Articles about AC Immune's Series D Round: